Credit Suisse’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Credit Suisse’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-86,174	Closed	-$3.1M	–	3965
2022 Q4	$3.1M	Buy	86,174 +77,173	+857%	+$1.93M	﹤0.01%	1621
2022 Q3	$136K	Buy	9,001 +127	+1%	+$2.06K	﹤0.01%	3360
2022 Q2	$119K	Buy	+8,874	New	+$141K	﹤0.01%	3503

Credit Suisse's IMGO Position: Q1 2023 in Review

Credit Suisse sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q1 2023, closing a stake of 86,174 shares — an estimated $3.1M sold.

Credit Suisse first reported a position in IMGO in Q2 2022 and held it in 3 quarters. The position peaked at $3.1M in Q4 2022. 0 funds tracked by Wall St. Rank hold IMGO as of Q1 2023.

Credit Suisse reported no remaining Imago BioSciences, Inc. Common stock position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 86,174 Imago BioSciences, Inc. Common stock shares in Q1 2023, an estimated $3.1M.
Credit Suisse first reported a position in Imago BioSciences, Inc. Common stock in Q2 2022 and held it in 3 quarters.
Credit Suisse's Imago BioSciences, Inc. Common stock position peaked at $3.1M in Q4 2022.
0 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.